• Publications
  • Influence
Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
The efficacy of oral cibenzoline (260 mg/day and 320 mg/day) and flecainide (200 mg/day and 300 mg/day) in the conversion of chronic atrial fibrillation to sinus rhythm were compared in 31 patientsExpand
  • 15
  • 1
Changes in the Canine Plasma Lipidome after Short- and Long-Term Excess Glucocorticoid Exposure
Glucocorticoids (GCs) are critical regulators of metabolic control in mammals and their aberrant function has been linked to several pathologies. GCs are widely used in human and veterinary clinicalExpand
  • 7
  • 1
Effects of Intravenous Cibenzoline on Ventricular Vulnerability and Electrophysiology in Patients with Sustained Ventricular Tachycardia in Comparison to a Control Group
The electrophysiologic effects of intravenous (i.v. 1.5 mg/kg) cibenzoline were investigated in 13 patients with organic heart disease and supraventricular arrhythmias (control group) and 13 patientsExpand
  • 7
Quantification of cibenzoline and its imidazole metabolite by high-performance liquid chromatography in human serum.
Cibenzoline, 4,5-dihydro-Z(2,2-diphenylcyclopropyl) -lH-imidazole, is a new class 1 antiarrhythmic drug chemically not related to any other class 1 antiarrhythmic agent. The imidazole metabolite ofExpand
  • 2
  • PDF
[Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
The electrophysiologic effects of the new class-1 antiarrhythmic drug cibenzoline (1.5 mg/kg within 10 min, followed by an infusion of 0.5 mg for 30 min) were investigated in six patients withExpand
Canine lipoprotein separation and characterization of the canine lipidome in healthy and prednisolone treated beagles
Changes in the lipid metabolism are known to mediate several diseases (e.g. atherosclerosis, coronary artery disease). The potential of lipidomics is increasingly recognized as clinical tool toExpand